The RNA-binding protein LARP1 is a cancer therapeutic target
Essam Ghazaly(Queen Mary University of London), Sarah P. Blagden(Churchill Hospital), Daishan Jiang, John Le Quesne, Manuela Mura(Ovarian Cancer Action), Chathunissa Gnanaranjan(Queen Mary University of London), Anil K. Sood(The Ohio State University Wexner Medical Center), James Chettle(University of Oxford), Selanere L. Mangala(Food Research Institute), Cristian Rodriguez‐Aguayo(The University of Texas MD Anderson Cancer Center), G. Lopez‐Berestein(The University of Texas MD Anderson Cancer Center), Chara Stavraka(King's College London)
Oxford University Research Archive (ORA) (University of Oxford)
January 1, 2017
Cited by 1
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Paraneoplastic Thrombocytosis in Ovarian Cancer
|New England Journal of Medicine|2012|822
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
|New England Journal of Medicine|2008|719